🟢 Marker Therapeutics is trading 14% up today with no clear catalyst identified

Marker Therapeutics is trading at $1.34, up +13.98%, with no clear company-specific announcement identified for September 8, 2026.

• The official release page lists March 18, 2026, as its latest 2026 release.
• H.C. Wainwright’s Buy rating and $10 price target were reiterated; the August 21 action is not a new September 8 catalyst.
• Broader U.S. markets were lower, so the gain is not clearly explained by market direction.